Conventional vs high-sensitive troponins in acute exacerbations of chronic obstructive pulmonary disease

Huiying Xu1, Joo Hor Tan2, John Arputhan Abisheganaden1

  • 1Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, Singapore.

Insights

Predictors for abnormal cardiac troponin (cTn) levels differ between conventional and high-sensitive assays during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Interpretation of cTn results in AECOPD requires consideration of these assay-specific factors.

Area of Science:

  • Cardiology
  • Pulmonology
  • Clinical Chemistry

Background:

  • Cardiac troponins (cTn), both conventional and high-sensitive (hscTn) assays, are frequently utilized during acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
  • Understanding factors influencing abnormal cTn levels is crucial for accurate diagnosis and patient management in this clinical setting.

Purpose of the Study:

  • To compare the factors that predict abnormal results for conventional cTn assays versus hscTn assays in patients presenting with AECOPD.
  • To identify specific clinical and biochemical predictors that differentiate between the two troponin assay types.

Main Methods:

  • A retrospective study analyzed data from AECOPD patients who underwent either conventional or hscTn testing.
  • Binary logistic regression was employed to identify significant predictors for elevated conventional cTn (>0.5 µg/L) and hscTn (>40 ng/L).

Main Results:

  • The study included 466 patients in the conventional cTn group and 313 in the hscTn group.
  • Ischemic electrocardiographic changes were the sole significant predictor for abnormal conventional cTn (OR 6.662, p=0.028).
  • B-type natriuretic peptide levels (Adj OR 1.004, p=0.010) and SpO2/FiO2 ratio (Adj OR 0.115, p=0.026) significantly predicted abnormal hscTn.

Conclusions:

  • The predictors for abnormal cardiac troponin levels vary significantly between conventional and high-sensitive assays.
  • These assay-specific differences must be considered when interpreting cTn results in the context of AECOPD to avoid misdiagnosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
89
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
284
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
530
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
131